Corcept Therapeutics Incorporated · NASDAQ:CORT
Ingalls & Snyder LLC reported a 7.80% stake in Corcept Therapeutics Incorporated (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 21, 2025
Ingalls & Snyder LLC reported a 7.80% stake in Corcept Therapeutics Incorporated, 8,173,721 shares, as a passive investor on Dec 31, 2024. Filed Feb 21, 2025 (Schedule 13G/A).
- Stake
- 7.80%
- Shares
- 8,173,721
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| INGALLS & SNYDER LLC | 7.80% | 8,173,721 |
Source
Related
- Corcept Therapeutics Incorporated
- Ingalls & Snyder LLC
- Corcept Therapeutics Incorporated shareholders
- Schedule 13G/A · Ingalls & Snyder LLC · Apr 21, 2026
- Form 4 · Wilson James N · Oct 16, 2026
- Form 4 · Vieira Roberto Wandenkolk · Oct 5, 2026
- Form 4 · Maduck Sean · Oct 5, 2026
- Form 4 · Lyon Joseph Douglas · Oct 5, 2026
- Form 4 · Robb Gary Charles · Sep 28, 2026